Universal serine oligopeptide synthesis method
By connecting serine one by one on the solid-phase resin carrier, combining the deprotection and washing steps, the problem of chain length control and purification of serine short peptide synthesis in the prior art is solved, and efficient synthesis of serine short peptide and environmentally friendly solid-phase synthesis are achieved. method.
Patent Information
- Application Number
- CN202411225357.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-03
- Publication Date
- 2024-11-26
AI Technical Summary
The prior art is difficult to efficiently synthesize and accurately control the chain length of serine short peptides, and solid phase synthesis methods have shortcomings in purification and operation automation.
Rink amind MBHA resin is used as a solid phase resin carrier, and serine is connected one by one through condensation reaction, combined with appropriate deprotection and washing steps to achieve the synthesis of serine tripeptides, and the fixed chain length is determined by precisely controlling the amount of serine.
It realizes efficient synthesis of serine short peptides and precise chain length control, simplifies the purification process, reduces the amount of reagents and environmental pollution, and is suitable for the synthesis of short-chain peptides.
Abstract
Description
Technical Field
[0001] The present invention relates to a general method for synthesizing serine short peptides Background Art
[0002] Serine peptides are a class of short-chain polypeptides composed of amino acids such as serine. They have high biological activity and permeability and are widely used in the field of biomaterials. Taking advantage of the unique advantages of serine peptides, serine peptides can be applied to the medical field. As a drug carrier, due to its good biocompatibility and degradability, it can deliver drugs to specific tissues or cells, improve the efficacy of drugs and reduce side effects. Some serine peptides themselves have the effect of treating diseases. For example, some serine peptides have antibacterial, antiviral, antioxidant and other activities, and can be used to treat infectious diseases, inflammatory diseases and oxidative stress-related diseases. In addition, they can also be used as diagnostic reagents to detect specific biomolecules or disease markers. In addition to the medical field, they are used as moisturizers, antioxidants, whitening agents, etc. in the cosmetics field, and can also be used as food additives in the food field.
[0003] Solid phase synthesis has the advantages of simplifying purification, improving reaction efficiency and facilitating automated operation, and because the reagents act relatively concentratedly on the substrate, the diffusion and waste of the reagents in the solution are reduced, thereby reducing the amount of reagents used. It reduces pollution to the environment and conforms to the development concept of green chemistry. The present invention first connects the carboxyl group of the first serine to an insoluble resin carrier to form a solid-phase supported serine. Then activated serine acid is added in sequence, and the serines are connected one by one through a condensation reaction to form a peptide chain. After each step of the reaction, the unreacted reagents and by-products can be removed by washing. Finally, a suitable cutting agent is used to cut the synthesized short peptide from the resin and purify it. For a serine short peptide with a fixed chain length, the amount of serine added can be accurately controlled according to the required chain length. Summary of the invention
[0004] The object of the present invention is to provide a general method for synthesizing short serine peptides.
[0005] The present invention takes the synthesis of serine tripeptide as an example, and uses Rink amind MBHA resin (100-200 mesh, 0.505 mol / g, cross-linking degree 1%) as a carrier to synthesize serine short peptide on the solid phase resin bead carrier.
[0006] The resin (1 eq) was swollen in three times the volume of reformed dichloromethane for 30 min and deprotected with 20% piperidine in N,N-dimethylformamide (DMF) for 15 min. Benzotriazole-N,N,N',N'-tetramethyluronium hexafluorophosphate (HBTU) (3 eq), 1-hydroxybenzotriazole (HOBT) (3 eq), N,N-diisopropylethylamine (DIEA) (6 eq) and Fmoc-D-Ser(OtBu)-OH (3 eq) were dissolved in DMF and reacted for 5 min to activate the serine functional group. Then it was added to the resin and shaken on a shaker at room temperature for 2 h. It was washed repeatedly with DMF and dichloromethane three times, and the last time with DMF. The serine was successfully attached by KAISER detection.
[0007] Continue to use DMF containing 20% piperidine for deprotection, repeat the above operation, react for 2 hours each time, and successfully connect a serine, repeat three times to obtain a serine tripeptide. Other serine short peptides can be carried out according to this operation, but this synthesis method is suitable for short peptides with shorter chain lengths, and the number of serines connected can be determined. It is very meaningful for the application of serine short peptides.
[0008] Serine short peptides have important biological significance and broad application prospects. With the continuous deepening of research, more of their functions and applications will be gradually revealed.
Claims
1. A general method for synthesizing serine short peptides, wherein the method for synthesizing serine short peptides refers to using resin balls as carriers to connect serine to the insoluble solid phase carrier, and the serine short peptides can be obtained without separation and purification in the whole process.
2. The serine short peptide as claimed in claim 1, which may have a fixed number of serines.
3. The serine short peptides obtained by this method have application potential in the fields of medicine, cosmetics, food and agriculture.
